title: Reply to "Pharmacokinetic and Analytical Issues in Busulfan Area Under the Curve Estimation and Simulation".
authors.affiliation: Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacy, The Hospital for Sick Children, Toronto, Ontario, Canada; Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: L Lee
authors.initials: LL
authors.lastname: Dupuis
authors.affiliation: Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacy, The Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: Jamie H
authors.initials: JH
authors.lastname: Zao
authors.affiliation: Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada; Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: Tal
authors.initials: T
authors.lastname: Schechter
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D002066:Busulfan / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008297:Male; D019172:Transplantation Conditioning / Q000379:methods*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D002066:Busulfan